News

Tackling Lyme Disease with Immunity

It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. About 30,000 Lyme disease cases are reported to the Centers for Disease Control and Prevention each year, but that number is likely far lower than the actual number of people diagnosed each year. Some estimates suggest that nearly 500,000 people get Lyme disease annually in the U.S. alone.

ISB Associate Professor Dr. Naeha Subramanian participated in ISB’s latest Research Roundtable event. Lyme disease is just one of the research areas studied by the Subramanian Lab. Subramanian delivered a presentation called “Tackling Lyme Disease with Immunity,” which you can watch here or by clicking play on the video at the top of this story.

Research Roundtables

ISB is hosting a series of Research Roundtable conversations throughout 2021 that will feature our leading scientists discussing their latest research. These events are designed for the novice scientist and the expert alike, and are open to anyone interested in the topics. Featured scientists will also answer your questions.

Next up in our series is Dr. Andrew Magis, who on September 21 will discuss identifying markers for cancer years before diagnosis (sign up here).

Past Research Roundtable events have featured ISB Co-founder Dr. Lee Hood, microbiome specialist and ISB Assistant Professor Dr. Sean Gibbons, and Alzheimer’s disease expert and ISB Senior Research Scientist Dr. Jared Roach. You can read about their talks and watch their presentations here, here and here, respectively.

Recent Articles

  • Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

    Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.

  • Dr. Naeha Subramanian

    Dr. Naeha Subramanian Promoted to Associate Professor

    Dr. Naeha Subramanian – an expert in immunology, innate immunity, and host-pathogen interactions, and head of ISB’s Subramanian Lab – has been promoted to Associate Professor. “I am honored with this promotion and excited about the incredible research being conducted in my lab. It is a pleasure and privilege to tackle exciting questions everyday,” she said.

  • Drs. Naeha Subramanian, Leah Rommereim Gilmore, and Ajay Suresh Akhade

    Small, Persistent Increase in the Expression of NOD1 May Promote Cancer Risk

    ISB researchers have found that a small, persistent increase in the expression of NOD1 could be responsible for higher cancer risks. The research team found that a slight 1.5-fold uptick in NOD1 expression can activate the protein and downstream signaling pathways in a manner similar to vast (30- to 200-fold) overexpression.